NO910267D0 - Krystallinsk hydroklorid av nye beta-laktamantibiotika ogfremgangsmaate derav. - Google Patents

Krystallinsk hydroklorid av nye beta-laktamantibiotika ogfremgangsmaate derav.

Info

Publication number
NO910267D0
NO910267D0 NO910267A NO910267A NO910267D0 NO 910267 D0 NO910267 D0 NO 910267D0 NO 910267 A NO910267 A NO 910267A NO 910267 A NO910267 A NO 910267A NO 910267 D0 NO910267 D0 NO 910267D0
Authority
NO
Norway
Prior art keywords
lactamantibiotics
crystallinic
hydrochloride
procedures
new beta
Prior art date
Application number
NO910267A
Other languages
English (en)
Other versions
NO910267L (no
Inventor
Ralph Robert Pfeiffer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO910267D0 publication Critical patent/NO910267D0/no
Publication of NO910267L publication Critical patent/NO910267L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO91910267A 1990-01-26 1991-01-23 Krystallinsk hydroklorid av nye beta-laktam-antibiotika og fremgangsmaate for dens fremstilling NO910267L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47048690A 1990-01-26 1990-01-26

Publications (2)

Publication Number Publication Date
NO910267D0 true NO910267D0 (no) 1991-01-23
NO910267L NO910267L (no) 1991-07-29

Family

ID=23867812

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910267A NO910267L (no) 1990-01-26 1991-01-23 Krystallinsk hydroklorid av nye beta-laktam-antibiotika og fremgangsmaate for dens fremstilling

Country Status (19)

Country Link
EP (1) EP0439353B1 (no)
JP (1) JPH04234880A (no)
KR (1) KR910014378A (no)
CN (1) CN1053611A (no)
AU (1) AU631960B2 (no)
CA (1) CA2034592C (no)
DE (1) DE69118933T2 (no)
ES (1) ES2087240T3 (no)
FI (1) FI910365A (no)
HU (1) HU208972B (no)
IE (1) IE910251A1 (no)
IL (1) IL96979A0 (no)
MX (1) MX24247A (no)
NO (1) NO910267L (no)
NZ (1) NZ236868A (no)
PT (1) PT96531A (no)
RU (1) RU1825365C (no)
YU (1) YU12191A (no)
ZA (1) ZA91428B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
WO1999024441A1 (en) * 1997-11-10 1999-05-20 Dsm N.V. Crystallization of beta-lactam compounds
AU2003283624A1 (en) * 2002-11-21 2004-06-15 Ranbaxy Laboratories Limited Monohydrate solvates of loracarbef

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5672698A (en) * 1979-11-14 1981-06-16 Kyowa Hakko Kogyo Co Ltd Preparation of optically active cephalosporin analogue
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
YU46699B (sh) * 1987-10-06 1994-04-05 Eli Lilly And Co. Kristalni monohidratni oblik 1-karbacefalosporina
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2002597C (en) * 1988-11-14 1999-03-23 Thomas M. Eckrich Solvates of b-lactam antibiotic

Also Published As

Publication number Publication date
IE910251A1 (en) 1991-07-31
CA2034592C (en) 2001-06-05
MX24247A (es) 1993-11-01
CA2034592A1 (en) 1991-07-27
IL96979A0 (en) 1992-03-29
NZ236868A (en) 1992-04-28
HUT57207A (en) 1991-11-28
HU208972B (en) 1994-02-28
JPH04234880A (ja) 1992-08-24
RU1825365C (ru) 1993-06-30
PT96531A (pt) 1991-10-15
FI910365A (fi) 1991-07-27
DE69118933T2 (de) 1996-10-02
HU910263D0 (en) 1991-08-28
ZA91428B (en) 1992-09-30
YU12191A (sh) 1994-01-20
FI910365A0 (fi) 1991-01-24
AU631960B2 (en) 1992-12-10
EP0439353B1 (en) 1996-04-24
EP0439353A1 (en) 1991-07-31
DE69118933D1 (de) 1996-05-30
AU6992391A (en) 1991-08-01
KR910014378A (ko) 1991-08-31
CN1053611A (zh) 1991-08-07
NO910267L (no) 1991-07-29
ES2087240T3 (es) 1996-07-16

Similar Documents

Publication Publication Date Title
NO914602L (no) Nye indan- og kinolin-derivater
NO932176D0 (no) Kinolin-, naftyridin- og pyridobenzoksazinderivater
FI903558A0 (fi) Avskiljningsanordning foer avskiljning av antigener.
NO894539D0 (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
NO890045L (no) Baatskrog og fremgangsmaate for fremstilling og belegging derav.
NO930156L (no) Nye oksazolylderivater
NO303446B1 (no) Nye 2-sakkarinylmetylaryl- og -aryloksyacetater, preparater og anvendelse derav
NO900866D0 (no) Kopolymerblandinger og avendelse av slike.
NO914288L (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO934426D0 (no) Nye amidoalkyl- og imidoalkylpipera-ziner
NO994505D0 (no) Forbedret fremgangsmÕte for fremstilling av tiazolidindioner og nye tiazolidindioner
NO932129D0 (no) Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater
NO910267D0 (no) Krystallinsk hydroklorid av nye beta-laktamantibiotika ogfremgangsmaate derav.
DK0381135T3 (da) Nye hydroxyperoxider og deres anvendelse
NO911118D0 (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO982105L (no) Nye mellomprodukter og deres anvendelse for fremstilling av N,N'-broslÕtte bisindolylmaleimider
NO924900L (no) Nye tiazoler
NO922608D0 (no) Nye cefalosporinforbindelser og fremgangsmaater til deres fremstilling
NO910135L (no) Fremgangsmaate for fremstilling og anvendelse av et nytt antibiotikum alisamycin.
DE69130337T2 (de) Medium, Herstellungsverfahren desselben, Informationsverarbeitungsvorrichtung und Informationsverarbeitungsverfahren
DK186791D0 (da) Nye enzymer
NO942051D0 (no) Nye tiosemikarbazontioner
KR910014300U (ko) 논두렁의 보호장치
NO952937D0 (no) Nye substituerte tiosemikarbazon derivater